Naive CD4+T Cells Modified to Express a ROR1-Specific CAR Mediate Anti-Tumor Activity and Provide Superior Help to CD8+ROR1-CAR T Cells

被引：0
|
作者：
Hudecek, Michael [1 ]
Lupo-Stanghellini, Maria-Teresa [1 ]
Kosasih, Paula [1 ]
Bet, Jeannette [1 ]
Paszkiewicz, Paulina [1 ]
Maloney, David G. [1 ]
Jensen, Michael C. [2 ]
Rader, Christoph [3 ]
Riddell, Stanley R. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[2] Seattle Childrens Res Inst, Ctr Childhood Canc Res, Seattle, WA USA
[3] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：294 / 294
页数：1
相关论文
共 50 条
  • [21] Provision of CD4+T cell help preferentially enhances anti-tumor immunity of high avidity T cells
    Zhu, Zigiang
    Singh, Vinod
    Bronte, Vincenzo
    Feigenbaum, Lionel
    Hurwitz, Arthur
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [22] CD8+CD39+T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer
    Zhu, Wenjie
    Zhao, Zihan
    Feng, Baofu
    Yu, Wenhao
    Li, Ji
    Guo, Hongqian
    Yang, Rong
    ONCOTARGETS AND THERAPY, 2021, 14 : 2149 - 2161
  • [23] Depletion of Tregs from CD4+ CAR-T cells enhances the tumoricidal effect of CD8+ CAR-T cells in anti-CD19 CAR-T therapy
    Sun, Yunyan
    Liu, Jinyan
    Zhan, Dong
    Wei, Jia
    Li, XianShi
    Zhang, Rui
    Duan, Ci
    Zhang, Disi
    Tang, Xiaorong
    Lin, Tuo
    Li, Limei
    Lai, Xun
    FEBS JOURNAL, 2024,
  • [24] CAR-T cells targeting CD38 and LMP1 and anti-tumor activity against NK/T cell lymphoma
    Li, Hongwen
    Shi, Zhuangzhuang
    Gao, Yuyang
    Li, Zhaoming
    Zhang, Mingzhi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Anti-CD1a CAR T cells to selectively target T-ALL
    Maciocia, Paul M.
    Pule, Martin A.
    BLOOD, 2019, 133 (21) : 2246 - 2247
  • [26] Key role of CD4+T cells in determining CD8 function during CAR-T cell manufacture
    Melenhorst, J. Joseph
    Oliveira, Beatriz C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (03)
  • [27] ROLE OF P21 IN CD4+T CELLS IN THE ANTI-TUMOR RESPONSE
    Thoma, Oana-Maria
    Matthe, Diana
    Schurer, Hendrik
    Kramer, Viktoria
    Menchicchi, Bianca
    Neurath, Markus
    Waldner, Maximilian
    GASTROENTEROLOGY, 2020, 158 (06) : S295 - S295
  • [28] Bystander Activation and Anti-Tumor Effects of CD8+T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+T Cell Help
    Monjazeb, Arta M.
    Tietze, Julia K.
    Grossenbacher, Steven K.
    Hsiao, Hui-Hua
    Zamora, Anthony E.
    Mirsoian, Annie
    Koehn, Brent
    Blazar, Bruce R.
    Weiss, Jonathan M.
    Wiltrout, Robert H.
    Sckisel, Gail D.
    Murphy, William J.
    PLOS ONE, 2014, 9 (08):
  • [29] PD-1 blocking strategy for enhancing the anti-tumor effect of CAR T cells targeted CD105
    Wang, Xi
    Lai, Zhiheng
    Pang, Yanyang
    Sun, Qinghui
    Yang, Wenli
    Wang, Wu
    HELIYON, 2023, 9 (01)
  • [30] Engineered NK-like NKG2C+CD8 T cells mediate superior anti-tumor efficacy over conventional CD8 T cells and NK cells
    Lupo, Kyle
    Panjwani, M. Kazim
    Daniyan, Anthony
    Klebanoff, Christopher
    Hsu, Katharine
    CANCER RESEARCH, 2024, 84 (06)
12345